SOCS1 (Suppressor of cytokine signaling 1; also JAB/SSI-1) is a cytokine-inducible intracellular protein that acts as a potent negative-feedback inhibitor of JAK-STAT signaling, with a particularly essential role in limiting type I and type II interferon (especially IFN-gamma) responses, as well as IL2, IL4, IL6 and LIF signaling. It has a modular architecture comprising an N-terminal kinase inhibitory region (KIR), an extended SH2 subdomain (ESS), a central SH2 domain, and a C-terminal SOCS box. SOCS1 docks through its SH2 domain onto phosphotyrosine in the activation loop of receptor- associated Janus kinases (JAK1, JAK2 and TYK2), while its KIR acts as a pseudosubstrate that occludes the kinase substrate-binding groove, thereby directly inhibiting JAK catalytic activity and downstream STAT phosphorylation. Through its SOCS box, SOCS1 recruits the Elongin BC complex and a Cullin (CUL2/CUL5)/RBX1 scaffold to form an ECS (Elongin BC-Cullin-SOCS box) E3 ubiquitin ligase in which SOCS1 serves as the substrate- recognition subunit, targeting bound proteins (such as JAK2, IRS proteins and NF-kB RelA) for polyubiquitination and proteasomal degradation. SOCS1 thereby contributes to the termination of cytokine signaling and to immune homeostasis; it acts as a tumor suppressor and its loss or haploinsufficiency causes interferon-driven autoinflammatory and autoimmune disease.
| GO Term | Evidence | Action | Reason |
|---|---|---|---|
|
GO:0046426
negative regulation of receptor signaling pathway via JAK-STAT
|
IBA
GO_REF:0000033 |
ACCEPT |
Summary: Phylogenetically inferred negative regulation of JAK-STAT signaling. This is the central, defining function of SOCS1, supported by the founding experimental papers and conserved across orthologs.
Reason: Core SOCS1 function; consistent with experimental evidence (PMID:9202125, PMID:9202126) and conserved across the SOCS1 family.
|
|
GO:0005126
cytokine receptor binding
|
IBA
GO_REF:0000033 |
KEEP AS NON CORE |
Summary: Phylogenetically inferred cytokine receptor binding. SOCS1 docks onto activated cytokine receptor / JAK complexes via its SH2 domain (e.g. IFNGR1), so binding to receptor components is plausible, but the informative molecular function is its kinase binding/inhibition rather than receptor binding per se.
Reason: Consistent with SH2-mediated docking onto receptor complexes, but secondary to the core kinase-inhibitor / ubiquitin-adaptor functions.
|
|
GO:0019221
cytokine-mediated signaling pathway
|
IBA
GO_REF:0000033 |
KEEP AS NON CORE |
Summary: SOCS1 acts within cytokine-mediated signaling pathways as a negative-feedback regulator. Accurate but general; the more specific term is negative regulation of JAK-STAT signaling.
Reason: Correct but high-level; the negative-regulation JAK-STAT term captures the core role more precisely.
|
|
GO:0005634
nucleus
|
IEA
GO_REF:0000044 |
KEEP AS NON CORE |
Summary: Electronic subcellular-location annotation. SOCS1 is detected in the nucleus and has reported nuclear activities (e.g. targeting nuclear RelA/p53), but its primary site of action is the cytoplasm.
Reason: Supported by UniProt subcellular location (PubMed:16410555); non-core relative to cytoplasmic JAK regulation.
|
|
GO:0031410
cytoplasmic vesicle
|
IEA
GO_REF:0000044 |
KEEP AS NON CORE |
Summary: Electronic location annotation reflecting detection in perinuclear cytoplasmic vesicles upon interaction with FGFR3. Condition-specific localization.
Reason: Supported by UniProt (PubMed:16410555) but condition-specific and non-core.
|
|
GO:0032502
developmental process
|
IEA
GO_REF:0000117 |
MARK AS OVER ANNOTATED |
Summary: Very general ARBA-derived developmental-process annotation. Uninformative for SOCS1's specific function.
Reason: Root-level/very general term with no specific support; over-annotation.
|
|
GO:0035556
intracellular signal transduction
|
IEA
GO_REF:0000002 |
KEEP AS NON CORE |
Summary: InterPro-derived general signal-transduction annotation. SOCS1 indeed acts in intracellular signaling, but as a negative regulator; the term is high-level.
Reason: Correct but very general; superseded by the specific JAK-STAT negative-regulation term.
|
|
GO:0005515
protein binding
|
IPI
PMID:16273093 A quantitative protein interaction network for the ErbB rece... |
MARK AS OVER ANNOTATED |
Summary: Generic protein-binding annotation from an ErbB SH2/PTB protein-microarray network (interaction with ERBB2/P04626). Uninformative term per curation guidelines.
Reason: 'protein binding' is uninformative; high-throughput interaction not central to SOCS1 function.
|
|
GO:0005515
protein binding
|
IPI
PMID:16643902 The E3 ubiquitin ligase HOIL-1 induces the polyubiquitinatio... |
KEEP AS NON CORE |
Summary: Generic protein-binding annotation (interaction with ELOC/Q15369). The SOCS1-Elongin C interaction is biologically real and underlies the SOCS-box E3 adaptor function, but the GO term itself is uninformative.
Reason: Interaction is meaningful (Elongin C / SOCS-box) but the generic term does not convey the adaptor function captured in core_functions.
|
|
GO:0005515
protein binding
|
IPI
PMID:17183367 COMMD1 promotes the ubiquitination of NF-kappaB subunits thr... |
KEEP AS NON CORE |
Summary: Generic protein-binding annotation backing the ECS(SOCS1) complex with RelA/Elongin C/COMMD1. Biologically central to the ubiquitin-ligase adaptor role, but recorded under the uninformative 'protein binding' term.
Reason: Underlying interaction supports the E3 substrate-adaptor core function; term itself is generic.
|
|
GO:0005515
protein binding
|
IPI
PMID:18172216 SOCS1 is an inducible host factor during HIV-1 infection and... |
KEEP AS NON CORE |
Summary: Generic protein-binding annotation for the direct SOCS1-HIV-1 Gag interaction (via SOCS1 SH2). Host-pathogen interaction, not core cellular physiology.
Reason: Real direct interaction but virus-related and peripheral; generic term.
|
|
GO:0005515
protein binding
|
IPI
PMID:31980649 Extensive rewiring of the EGFR network in colorectal cancer ... |
MARK AS OVER ANNOTATED |
Summary: Generic protein-binding annotation from a large-scale KRAS/EGFR-network AP-MS study (interaction with ELOC/Q15369). Uninformative term, high-throughput context.
Reason: 'protein binding' is uninformative; high-throughput interaction.
|
|
GO:0005515
protein binding
|
IPI
PMID:32296183 A reference map of the human binary protein interactome. |
MARK AS OVER ANNOTATED |
Summary: Generic protein-binding annotation from the HuRI binary interactome (interaction with SH3GL1/Q99961). Uninformative term, context-free high-throughput screen.
Reason: 'protein binding' is uninformative; high-throughput interactome.
|
|
GO:0005515
protein binding
|
IPI
PMID:35512704 Systematic discovery of mutation-directed neo-protein-protei... |
MARK AS OVER ANNOTATED |
Summary: Generic protein-binding annotation from a cancer neoPPI screen (interaction with SMAD4/Q13485). Uninformative term.
Reason: 'protein binding' is uninformative; high-throughput screen.
|
|
GO:0019210
kinase inhibitor activity
|
IEA
GO_REF:0000107 |
MODIFY |
Summary: Kinase inhibitor activity transferred from the mouse ortholog. Correct in essence; the more specific and experimentally supported term is protein kinase inhibitor activity (GO:0004860).
Reason: Generalize-to-specific: SOCS1 specifically inhibits protein (tyrosine) kinases (JAKs); replace with protein kinase inhibitor activity.
Proposed replacements:
protein kinase inhibitor activity
|
|
GO:0043372
positive regulation of CD4-positive, alpha-beta T cell differentiation
|
IEA
GO_REF:0000107 |
KEEP AS NON CORE |
Summary: T-cell differentiation role transferred electronically from the mouse ortholog (O35716). Consistent with SOCS1's role in T-cell homeostasis but not a core molecular function.
Reason: Plausible from mouse ortholog; downstream immunophysiology, non-core.
|
|
GO:0043377
negative regulation of CD8-positive, alpha-beta T cell differentiation
|
IEA
GO_REF:0000107 |
KEEP AS NON CORE |
Summary: Electronic transfer from the mouse ortholog. Consistent with SOCS1's T-cell regulatory role; non-core.
Reason: Plausible from mouse ortholog; downstream immunophysiology, non-core.
|
|
GO:0016567
protein ubiquitination
|
IEA
GO_REF:0000041 |
ACCEPT |
Summary: UniPathway-derived protein-ubiquitination annotation. Reflects SOCS1's SOCS-box E3 ubiquitin ligase substrate-recognition role, which targets bound substrates for ubiquitination and proteasomal degradation.
Reason: Core process consistent with the ECS(SOCS1) E3 ligase adaptor function (PMID:17183367).
|
|
GO:0005654
nucleoplasm
|
IDA
GO_REF:0000052 |
KEEP AS NON CORE |
Summary: Immunofluorescence-based (HPA) nucleoplasm localization. SOCS1 has documented nuclear pools and nuclear substrates; primary functional site remains cytoplasmic.
Reason: Experimentally observed location; non-core relative to cytoplasmic JAK regulation.
|
|
GO:0030225
macrophage differentiation
|
IMP
PMID:32634427 Downregulation of microRNA-155-5p prevents immune thrombocyt... |
KEEP AS NON CORE |
Summary: SOCS1 (a miR-155-5p target) promotes macrophage M2 polarization via the PD1/PDL1 pathway in an immune thrombocytopenia model. Reflects a downstream contextual role in macrophage biology.
Reason: Experimental (IMP) but downstream/contextual; not a core molecular function. Defer to curator on the precise differentiation term.
|
|
GO:0005515
protein binding
|
IPI
PMID:23401859 DCNL1 functions as a substrate sensor and activator of culli... |
MARK AS OVER ANNOTATED |
Summary: Generic protein-binding annotation from a DCNL1/CUL2-neddylation study (with DCUN1D1/O14508). Consistent with SOCS1's CRL2/CRL5 substrate-receptor context but recorded under the uninformative 'protein binding' term.
Reason: 'protein binding' is uninformative; interaction is contextual to CRL machinery.
|
|
GO:0043372
positive regulation of CD4-positive, alpha-beta T cell differentiation
|
ISS
GO_REF:0000024 |
KEEP AS NON CORE |
Summary: Sequence-similarity transfer (from mouse O35716) of the CD4 T-cell differentiation role; duplicates the IEA annotation above. Non-core.
Reason: By-similarity immunophysiology; non-core.
|
|
GO:0043377
negative regulation of CD8-positive, alpha-beta T cell differentiation
|
ISS
GO_REF:0000024 |
KEEP AS NON CORE |
Summary: Sequence-similarity transfer of the CD8 T-cell differentiation role; duplicates the IEA annotation. Non-core.
Reason: By-similarity immunophysiology; non-core.
|
|
GO:0045591
positive regulation of regulatory T cell differentiation
|
IMP
PMID:22387553 Downregulation of inflammatory microRNAs by Ig-like transcri... |
UNDECIDED |
Summary: Annotation from a study of ILT3-induced CD8+ T suppressor cell differentiation in which SOCS1 is a direct miR-155 target. The cached abstract does not clearly establish a direct SOCS1 role in regulatory T cell differentiation; the supporting detail is in full text not available here.
Reason: Cannot verify the specific Treg-differentiation claim from the cached abstract; per guidelines use UNDECIDED rather than overruling the experimental annotation.
|
|
GO:0046426
negative regulation of receptor signaling pathway via JAK-STAT
|
IMP
PMID:25019494 MiR-221 accentuates IFN's anti-HCV effect by downregulating ... |
ACCEPT |
Summary: Experimental support: miR-221 downregulation of SOCS1/SOCS3 potentiates IFN's anti-HCV effect, with SOCS1/SOCS3 described as established inhibitors of the IFN/JAK/STAT pathway. Reinforces the core negative-regulation function.
Reason: Core JAK-STAT negative-regulation function, experimentally supported.
|
|
GO:0005829
cytosol
|
TAS
Reactome:R-HSA-6785860 |
ACCEPT |
Summary: Cytosolic localization (Reactome). SOCS1 acts on receptor-associated JAKs in the cytoplasm; this is its primary functional compartment.
Reason: Primary site of action; consistent across sources.
|
|
GO:0005829
cytosol
|
TAS
Reactome:R-HSA-877269 |
ACCEPT |
Summary: Cytosolic localization (Reactome), from the SOCS-1/SOCS-3 binding to p-JAK2 event. Consistent with the core cytoplasmic JAK-regulation role.
Reason: Primary functional compartment.
|
|
GO:0005829
cytosol
|
TAS
Reactome:R-HSA-8983011 |
ACCEPT |
Summary: Cytosolic localization (Reactome). Redundant with other cytosol annotations.
Reason: Consistent cytosolic localization.
|
|
GO:0005829
cytosol
|
TAS
Reactome:R-HSA-9705738 |
ACCEPT |
Summary: Cytosolic localization (Reactome), from the SOCS1/3 CSF3R ubiquitination event. Consistent with the SOCS-box E3 adaptor activity occurring in the cytoplasm.
Reason: Consistent cytosolic localization.
|
|
GO:0005829
cytosol
|
TAS
Reactome:R-NUL-1169195 |
ACCEPT |
Summary: Cytosolic localization (Reactome). Redundant cytosol annotation.
Reason: Consistent cytosolic localization.
|
|
GO:0019210
kinase inhibitor activity
|
ISS
GO_REF:0000024 |
MODIFY |
Summary: Sequence-similarity transfer of kinase inhibitor activity. As with the IEA version, the specific supported term is protein kinase inhibitor activity (GO:0004860).
Reason: Generalize-to-specific: replace with protein kinase inhibitor activity.
Proposed replacements:
protein kinase inhibitor activity
|
|
GO:0019221
cytokine-mediated signaling pathway
|
ISS
GO_REF:0000024 |
KEEP AS NON CORE |
Summary: Sequence-similarity transfer placing SOCS1 in cytokine-mediated signaling. Correct but general; SOCS1's specific role is negative regulation of JAK-STAT signaling.
Reason: Correct but high-level; superseded by the specific negative-regulation term.
|
|
GO:0046426
negative regulation of receptor signaling pathway via JAK-STAT
|
ISS
GO_REF:0000024 |
ACCEPT |
Summary: Sequence-similarity transfer of the core JAK-STAT negative-regulation function. Fully consistent with experimental evidence.
Reason: Core SOCS1 function, corroborated experimentally and by orthology.
|
|
GO:0046627
negative regulation of insulin receptor signaling pathway
|
ISS
GO_REF:0000024 |
KEEP AS NON CORE |
Summary: Sequence-similarity transfer (mouse O35716) of negative regulation of insulin receptor signaling. SOCS1 is reported to attenuate insulin/IGF signaling (e.g. via IRS targeting), but this is a secondary, context-specific role.
Reason: Plausible secondary role; non-core relative to cytokine/JAK regulation.
|
|
GO:0005159
insulin-like growth factor receptor binding
|
IPI
PMID:9727029 Interaction of human suppressor of cytokine signaling (SOCS)... |
KEEP AS NON CORE |
Summary: IPI annotation supported by the explicit statement that hSOCS-1 interacts strongly with IGF-IR in the two-hybrid assay. Real SH2-mediated interaction, but peripheral to SOCS1's canonical cytokine-signaling role.
Reason: Experimentally supported interaction (PMID:9727029) but a secondary, receptor-specific binding rather than a core function.
|
|
GO:0019901
protein kinase binding
|
IPI
PMID:9727029 Interaction of human suppressor of cytokine signaling (SOCS)... |
ACCEPT |
Summary: Protein kinase binding annotation (WITH JAK2/O60674). SOCS1 binding to activated JAKs through its SH2 domain is central to its mechanism; protein kinase binding is an informative, accurate molecular function.
Reason: Captures SOCS1's mechanistically essential binding to JAK kinases; core function.
|
|
GO:0046426
negative regulation of receptor signaling pathway via JAK-STAT
|
NAS
PMID:9727029 Interaction of human suppressor of cytokine signaling (SOCS)... |
ACCEPT |
Summary: Non-traceable author statement of the core JAK-STAT negative-regulation function. Consistent with the wealth of experimental evidence even though the assertion here is by analogy in a SOCS-2-focused paper.
Reason: Core function; abundantly supported elsewhere (PMID:9202125, PMID:9202126).
|
|
GO:0004860
protein kinase inhibitor activity
|
TAS
PMID:9202125 A family of cytokine-inducible inhibitors of signalling. |
ACCEPT |
Summary: Traceable-author-statement annotation of protein kinase inhibitor activity from the founding SOCS family paper. This is the precise, experimentally grounded core molecular function of SOCS1 (direct inhibition of JAK catalytic activity).
Reason: Core molecular function; directly supported by PMID:9202125 and PMID:9202126.
|
|
GO:0005737
cytoplasm
|
TAS
PMID:9202126 A new protein containing an SH2 domain that inhibits JAK kin... |
ACCEPT |
Summary: Cytoplasmic localization from the founding JAB paper. SOCS1 acts on cytoplasmic receptor-associated JAKs; cytoplasm/cytosol is its principal compartment.
Reason: Primary functional compartment; consistent with cytosol annotations.
|
Q: What is the full repertoire of physiological SOCS1 ubiquitination substrates beyond JAKs (e.g. NF-kB RelA, IRS1/2, FAK), and which are degraded versus non-degradatively regulated in primary immune cells?
Q: How is the balance between SOCS1's direct kinase-inhibitory (KIR/SH2) activity and its SOCS-box E3-adaptor activity tuned in different cytokine contexts?
Experiment: Separation-of-function mutants (KIR-dead vs SOCS-box-dead vs SH2-dead) expressed in SOCS1-null cells, with quantitative phospho-JAK/STAT and substrate-degradation readouts across IFN-gamma, IL2, IL4 and IL6 stimulation, to dissect the relative contributions of kinase inhibition and ubiquitin-mediated degradation.
Experiment: Proximity-labeling (BioID/TurboID) and ubiquitin-remnant proteomics in cytokine- stimulated primary T cells/macrophages to define the endogenous SOCS1 interactome and its degradation targets in a physiological setting.
Journal of research for the SOCS1 AI gene review. Provenance recorded inline.
PMID:9202126 β direct demonstration of JAK binding (JH1 kinase domain)
and inhibition of JAK catalytic activity. This is the basis for the
protein-kinase-inhibitor MF (GO:0004860) and the JAK-STAT negative regulation BP.
Mechanistic basis (crystal structure of SOCS1:JAK1 kinase domain, PMID:29662058,
Nat Commun 2018; PDB 6C7Y β not in local cache, used via WebSearch only):
SOCS1 inhibits JAK1/JAK2/TYK2 (but not JAK3) by its KIR acting as a pseudosubstrate
that blocks the JAK substrate-binding groove (His54 mimics the substrate tyrosine;
KIR wedges between the activation loop and the Ξ±G helix), while the SH2 domain docks
onto a phosphotyrosine in the JAK activation loop. This supports protein kinase
inhibitor activity (GO:0004860) and SH2 phosphotyrosine docking (GO:0042169 SH2
domain binding describes the reciprocal; for SOCS1 the relevant MF is binding via
its own SH2 to pTyr targets). UniProt DOMAIN note: "The ESS and SH2 domains are
required for JAK phosphotyrosine binding. Further interaction with the KIR domain is
necessary for signal and kinase inhibition."
PMID:23401859 β DCNL1/CUL2 neddylation study (with DCUN1D1/O14508, etc.).
All are appropriately KEEP_AS_NON_CORE or MARK_AS_OVER_ANNOTATED: "protein binding"
is uninformative per curation guidelines; none should be a core function.
IGF1R / IGF1R binding: PMID:9727029 β the paper is mainly about SOCS-2, but explicitly
assays SOCS-1 binding IGF-IR. Supports GO:0005159 (IGF receptor binding, IPI, WITH
IGF1R/P08069) and GO:0019901 protein kinase binding (IPI, WITH JAK2/O60674) and the
NAS GO:0046426 JAK-STAT negative regulation. These IGF/insulin-receptor links are
real but peripheral relative to the canonical cytokine/JAK role β non-core.
id: O15524
gene_symbol: SOCS1
product_type: PROTEIN
status: COMPLETE
taxon:
id: NCBITaxon:9606
label: Homo sapiens
description: >-
SOCS1 (Suppressor of cytokine signaling 1; also JAB/SSI-1) is a cytokine-inducible
intracellular protein that acts as a potent negative-feedback inhibitor of JAK-STAT
signaling, with a particularly essential role in limiting type I and type II interferon
(especially IFN-gamma) responses, as well as IL2, IL4, IL6 and LIF signaling. It has a
modular architecture comprising an N-terminal kinase inhibitory region (KIR), an
extended SH2 subdomain (ESS), a central SH2 domain, and a C-terminal SOCS box. SOCS1
docks through its SH2 domain onto phosphotyrosine in the activation loop of receptor-
associated Janus kinases (JAK1, JAK2 and TYK2), while its KIR acts as a pseudosubstrate
that occludes the kinase substrate-binding groove, thereby directly inhibiting JAK
catalytic activity and downstream STAT phosphorylation. Through its SOCS box, SOCS1
recruits the Elongin BC complex and a Cullin (CUL2/CUL5)/RBX1 scaffold to form an ECS
(Elongin BC-Cullin-SOCS box) E3 ubiquitin ligase in which SOCS1 serves as the substrate-
recognition subunit, targeting bound proteins (such as JAK2, IRS proteins and NF-kB
RelA) for polyubiquitination and proteasomal degradation. SOCS1 thereby contributes to
the termination of cytokine signaling and to immune homeostasis; it acts as a tumor
suppressor and its loss or haploinsufficiency causes interferon-driven autoinflammatory
and autoimmune disease.
references:
- id: GO_REF:0000002
title: Gene Ontology annotation through association of InterPro records with GO
terms
findings: []
- id: GO_REF:0000024
title: Manual transfer of experimentally-verified manual GO annotation data to orthologs
by curator judgment of sequence similarity
findings: []
- id: GO_REF:0000033
title: Annotation inferences using phylogenetic trees
findings: []
- id: GO_REF:0000041
title: Gene Ontology annotation based on UniPathway vocabulary mapping
findings: []
- id: GO_REF:0000044
title: Gene Ontology annotation based on UniProtKB/Swiss-Prot Subcellular Location
vocabulary mapping, accompanied by conservative changes to GO terms applied by
UniProt
findings: []
- id: GO_REF:0000052
title: Gene Ontology annotation based on curation of immunofluorescence data
findings: []
- id: GO_REF:0000107
title: Automatic transfer of experimentally verified manual GO annotation data to
orthologs using Ensembl Compara
findings: []
- id: GO_REF:0000117
title: Electronic Gene Ontology annotations created by ARBA machine learning models
findings: []
- id: PMID:16273093
title: A quantitative protein interaction network for the ErbB receptors using protein
microarrays.
findings: []
reference_review:
relevance: LOW
correctness: VERIFIED
review_notes: >-
Large-scale SH2/PTB protein-microarray network for ErbB receptors. Supports a
generic SOCS1-ERBB2 (P04626) protein interaction (GO:0005515), not a focused
SOCS1 functional study. Peripheral to SOCS1 physiology.
- id: PMID:16643902
title: The E3 ubiquitin ligase HOIL-1 induces the polyubiquitination and degradation
of SOCS6 associated proteins.
findings: []
reference_review:
relevance: LOW
correctness: VERIFIED
review_notes: >-
Primarily about SOCS6/HOIL-1. The IntAct interaction underlying the SOCS1
GO:0005515 annotation is with ELOC (Q15369). The paper does state the shared
SOCS-box principle that all SOCS proteins bind an Elongin BC E3 complex through
the common SOCS-box, consistent with SOCS1's Elongin-BC adaptor role.
- id: PMID:17183367
title: COMMD1 promotes the ubiquitination of NF-kappaB subunits through a cullin-containing
ubiquitin ligase.
findings: []
reference_review:
relevance: MEDIUM
correctness: VERIFIED
review_notes: >-
Demonstrates an ECS(SOCS1) E3 ligase containing Elongins B/C, Cul2 and SOCS1 that
ubiquitinates NF-kB RelA, with SOCS1 binding RelA as substrate. Strong support for
SOCS1's SOCS-box ubiquitin-ligase substrate-recognition adaptor function, although
the GOA annotation it backs is the generic GO:0005515 protein binding.
- id: PMID:18172216
title: SOCS1 is an inducible host factor during HIV-1 infection and regulates the
intracellular trafficking and stability of HIV-1 Gag.
findings: []
reference_review:
relevance: LOW
correctness: VERIFIED
review_notes: >-
Full text confirms SOCS1 directly binds HIV-1 Gag via its SH2 domain and that the
SOCS box is required for Gag particle production. Host-pathogen interaction;
supports GO:0005515 with gag (Q77YG1) but is not part of SOCS1's core cellular
physiology.
- id: PMID:22387553
title: Downregulation of inflammatory microRNAs by Ig-like transcript 3 is essential
for the differentiation of human CD8(+) T suppressor cells.
findings: []
reference_review:
relevance: LOW
correctness: UNVERIFIED
review_notes: >-
SOCS1 appears as a direct miR-155 target in ILT3-induced CD8+ T suppressor cells.
The abstract does not establish a direct SOCS1 role in regulatory T cell
differentiation; the IMP annotation to GO:0045591 rests on full text not in cache.
- id: PMID:23401859
title: DCNL1 functions as a substrate sensor and activator of cullin 2-RING ligase.
findings: []
reference_review:
relevance: LOW
correctness: VERIFIED
review_notes: >-
DCNL1/CUL2 neddylation study; SOCS1 is used as an ECS(SOCS1)/CRL2 component context.
Supports the generic GO:0005515 interaction (DCUN1D1) and is consistent with
SOCS1's CRL2/CRL5 substrate-receptor role.
- id: PMID:25019494
title: MiR-221 accentuates IFN's anti-HCV effect by downregulating SOCS1 and SOCS3.
findings: []
reference_review:
relevance: MEDIUM
correctness: VERIFIED
review_notes: >-
Identifies SOCS1 (and SOCS3) as miR-221 targets and explicitly describes them as
well established inhibitory factors on the IFN/JAK/STAT pathway, consistent with
SOCS1's core negative regulation of JAK-STAT signaling.
- id: PMID:31980649
title: Extensive rewiring of the EGFR network in colorectal cancer cells expressing
transforming levels of KRAS(G13D).
findings: []
reference_review:
relevance: LOW
correctness: VERIFIED
review_notes: >-
Large-scale AP-MS EGFR-network rewiring study; underlies a generic SOCS1-ELOC
(Q15369) interaction (GO:0005515). Not a focused SOCS1 functional characterization.
- id: PMID:32296183
title: A reference map of the human binary protein interactome.
findings: []
reference_review:
relevance: LOW
correctness: VERIFIED
review_notes: >-
HuRI all-by-all binary interactome; supports a generic SOCS1-SH3GL1 (Q99961)
interaction (GO:0005515). High-throughput, context-free.
- id: PMID:32634427
title: Downregulation of microRNA-155-5p prevents immune thrombocytopenia by promoting
macrophage M2 polarization via the SOCS1-dependent PD1/PDL1 pathway.
findings: []
reference_review:
relevance: MEDIUM
correctness: VERIFIED
review_notes: >-
SOCS1 is a validated miR-155-5p target; its up-regulation promotes macrophage M2
polarization via PD1/PDL1 in an ITP model. Supports a contextual role in macrophage
polarization (IMP, GO:0030225) rather than a core SOCS1 molecular function.
- id: PMID:35512704
title: Systematic discovery of mutation-directed neo-protein-protein interactions
in cancer.
findings: []
reference_review:
relevance: LOW
correctness: VERIFIED
review_notes: >-
Cancer neoPPI BRET screen; underlies a generic SOCS1-SMAD4 (Q13485) interaction
(GO:0005515). High-throughput screen, not a focused SOCS1 study.
- id: PMID:9202125
title: A family of cytokine-inducible inhibitors of signalling.
findings: []
reference_review:
relevance: HIGH
correctness: VERIFIED
review_notes: >-
Founding SOCS1 paper (Starr et al., Nature 1997). Cloned SOCS-1 by its ability to
inhibit IL6-induced macrophage differentiation; SOCS-1 inhibits IL6-induced
receptor phosphorylation and STAT activation and acts in a classic negative-
feedback loop. Direct support for the protein kinase inhibitor / JAK-STAT negative
regulation core functions.
- id: PMID:9202126
title: A new protein containing an SH2 domain that inhibits JAK kinases.
findings: []
reference_review:
relevance: HIGH
correctness: VERIFIED
review_notes: >-
Founding SOCS1/JAB paper (Endo et al., Nature 1997). Shows JAB binds the JAK2 JH1
kinase domain and that interaction with Jak1/Jak2/Jak3 markedly reduces their
tyrosine-kinase activity and suppresses STAT phosphorylation/activation. Direct
support for JAK binding and kinase inhibition.
- id: PMID:9727029
title: Interaction of human suppressor of cytokine signaling (SOCS)-2 with the insulin-like
growth factor-I receptor.
findings: []
reference_review:
relevance: MEDIUM
correctness: VERIFIED
review_notes: >-
Principally about SOCS-2, but the abstract explicitly states that hSOCS-1 protein
also interacted strongly with IGF-IR in the two-hybrid assay, supporting the SOCS1
IGF1R-binding (GO:0005159) and protein kinase binding (GO:0019901) IPI annotations.
The NAS GO:0046426 here is a by-analogy assertion.
- id: Reactome:R-HSA-6785860
title: Expression of SOCS1
findings: []
- id: Reactome:R-HSA-877269
title: SOCS-1 and SOCS-3 binds to p-JAK2
findings: []
- id: Reactome:R-HSA-8983011
title: Expression of STAT5 upregulated genes
findings: []
- id: Reactome:R-HSA-9705738
title: SOCS1,3 ubiquitinates CSF3R in SOCS1,3:p-4Y-CSF3R:CSF3 dimer complex
findings: []
- id: Reactome:R-NUL-1169195
title: SOCS binding to Ghr
findings: []
core_functions:
- description: >-
SOCS1 is a direct inhibitor of Janus kinase catalytic activity. It binds receptor-
associated JAK1, JAK2 and TYK2 (via its SH2 domain docking onto phosphotyrosine in
the JAK activation loop, with its kinase inhibitory region (KIR) acting as a
pseudosubstrate that blocks the kinase substrate-binding groove), markedly reducing
JAK tyrosine-kinase activity and suppressing downstream STAT phosphorylation and
activation.
molecular_function:
id: GO:0004860
label: protein kinase inhibitor activity
directly_involved_in:
- id: GO:0046426
label: negative regulation of receptor signaling pathway via JAK-STAT
locations:
- id: GO:0005829
label: cytosol
supported_by:
- reference_id: PMID:9202126
supporting_text: "Interaction of JAB with Jak1, Jak2 or Jak3 markedly reduces their tyrosine-kinase activity and suppresses the tyrosine-phosphorylation and activation of STATs."
- reference_id: PMID:9202125
supporting_text: "Expression of SOCS-1 inhibited both interleukin-6-induced receptor phosphorylation and STAT activation."
- description: >-
SOCS1 binds activated Janus kinases through its SH2 domain, recognizing
phosphotyrosine within the JAK JH1 (kinase) domain. This phosphotyrosine-dependent
docking onto the activated kinase is the prerequisite for kinase inhibition and for
delivering bound substrates to the ubiquitination machinery.
molecular_function:
id: GO:0019901
label: protein kinase binding
directly_involved_in:
- id: GO:0046426
label: negative regulation of receptor signaling pathway via JAK-STAT
locations:
- id: GO:0005829
label: cytosol
supported_by:
- reference_id: PMID:9202126
supporting_text: "JAB, which is a JAK-binding protein that interacts with the Jak2 tyrosine-kinase JH1 domain"
- description: >-
Through its C-terminal SOCS box, SOCS1 recruits the Elongin BC complex and a
Cullin (CUL2/CUL5)/RBX1 scaffold to assemble an ECS (Elongin BC-Cullin-SOCS box)
E3 ubiquitin ligase, acting as the substrate-recognition subunit that brings bound
target proteins to the ligase for polyubiquitination and subsequent proteasomal
degradation (e.g. NF-kB RelA in the ECS(SOCS1) complex).
molecular_function:
id: GO:1990756
label: ubiquitin-like ligase-substrate adaptor activity
directly_involved_in:
- id: GO:0016567
label: protein ubiquitination
locations:
- id: GO:0005829
label: cytosol
supported_by:
- reference_id: PMID:17183367
supporting_text: "COMMD1 accelerates the ubiquitination and degradation of NF-kappaB subunits through its interaction with a multimeric ubiquitin ligase containing Elongins B and C, Cul2 and SOCS1 (ECS(SOCS1))."
- reference_id: PMID:16643902
supporting_text: "All SOCS proteins bind an Elongin BC E3 ubiquitin ligase complex through the common Socs-box."
existing_annotations:
- term:
id: GO:0046426
label: negative regulation of receptor signaling pathway via JAK-STAT
evidence_type: IBA
original_reference_id: GO_REF:0000033
qualifier: involved_in
review:
summary: >-
Phylogenetically inferred negative regulation of JAK-STAT signaling. This is the
central, defining function of SOCS1, supported by the founding experimental papers
and conserved across orthologs.
action: ACCEPT
reason: >-
Core SOCS1 function; consistent with experimental evidence (PMID:9202125,
PMID:9202126) and conserved across the SOCS1 family.
- term:
id: GO:0005126
label: cytokine receptor binding
evidence_type: IBA
original_reference_id: GO_REF:0000033
qualifier: enables
review:
summary: >-
Phylogenetically inferred cytokine receptor binding. SOCS1 docks onto activated
cytokine receptor / JAK complexes via its SH2 domain (e.g. IFNGR1), so binding to
receptor components is plausible, but the informative molecular function is its
kinase binding/inhibition rather than receptor binding per se.
action: KEEP_AS_NON_CORE
reason: >-
Consistent with SH2-mediated docking onto receptor complexes, but secondary to the
core kinase-inhibitor / ubiquitin-adaptor functions.
- term:
id: GO:0019221
label: cytokine-mediated signaling pathway
evidence_type: IBA
original_reference_id: GO_REF:0000033
qualifier: involved_in
review:
summary: >-
SOCS1 acts within cytokine-mediated signaling pathways as a negative-feedback
regulator. Accurate but general; the more specific term is negative regulation of
JAK-STAT signaling.
action: KEEP_AS_NON_CORE
reason: >-
Correct but high-level; the negative-regulation JAK-STAT term captures the core
role more precisely.
- term:
id: GO:0005634
label: nucleus
evidence_type: IEA
original_reference_id: GO_REF:0000044
qualifier: located_in
review:
summary: >-
Electronic subcellular-location annotation. SOCS1 is detected in the nucleus and
has reported nuclear activities (e.g. targeting nuclear RelA/p53), but its primary
site of action is the cytoplasm.
action: KEEP_AS_NON_CORE
reason: >-
Supported by UniProt subcellular location (PubMed:16410555); non-core relative to
cytoplasmic JAK regulation.
- term:
id: GO:0031410
label: cytoplasmic vesicle
evidence_type: IEA
original_reference_id: GO_REF:0000044
qualifier: located_in
review:
summary: >-
Electronic location annotation reflecting detection in perinuclear cytoplasmic
vesicles upon interaction with FGFR3. Condition-specific localization.
action: KEEP_AS_NON_CORE
reason: >-
Supported by UniProt (PubMed:16410555) but condition-specific and non-core.
- term:
id: GO:0032502
label: developmental process
evidence_type: IEA
original_reference_id: GO_REF:0000117
qualifier: involved_in
review:
summary: >-
Very general ARBA-derived developmental-process annotation. Uninformative for
SOCS1's specific function.
action: MARK_AS_OVER_ANNOTATED
reason: >-
Root-level/very general term with no specific support; over-annotation.
- term:
id: GO:0035556
label: intracellular signal transduction
evidence_type: IEA
original_reference_id: GO_REF:0000002
qualifier: involved_in
review:
summary: >-
InterPro-derived general signal-transduction annotation. SOCS1 indeed acts in
intracellular signaling, but as a negative regulator; the term is high-level.
action: KEEP_AS_NON_CORE
reason: >-
Correct but very general; superseded by the specific JAK-STAT negative-regulation
term.
- term:
id: GO:0005515
label: protein binding
evidence_type: IPI
original_reference_id: PMID:16273093
qualifier: enables
review:
summary: >-
Generic protein-binding annotation from an ErbB SH2/PTB protein-microarray network
(interaction with ERBB2/P04626). Uninformative term per curation guidelines.
action: MARK_AS_OVER_ANNOTATED
reason: >-
'protein binding' is uninformative; high-throughput interaction not central to
SOCS1 function.
- term:
id: GO:0005515
label: protein binding
evidence_type: IPI
original_reference_id: PMID:16643902
qualifier: enables
review:
summary: >-
Generic protein-binding annotation (interaction with ELOC/Q15369). The
SOCS1-Elongin C interaction is biologically real and underlies the SOCS-box E3
adaptor function, but the GO term itself is uninformative.
action: KEEP_AS_NON_CORE
reason: >-
Interaction is meaningful (Elongin C / SOCS-box) but the generic term does not
convey the adaptor function captured in core_functions.
- term:
id: GO:0005515
label: protein binding
evidence_type: IPI
original_reference_id: PMID:17183367
qualifier: enables
review:
summary: >-
Generic protein-binding annotation backing the ECS(SOCS1) complex with RelA/Elongin
C/COMMD1. Biologically central to the ubiquitin-ligase adaptor role, but recorded
under the uninformative 'protein binding' term.
action: KEEP_AS_NON_CORE
reason: >-
Underlying interaction supports the E3 substrate-adaptor core function; term itself
is generic.
- term:
id: GO:0005515
label: protein binding
evidence_type: IPI
original_reference_id: PMID:18172216
qualifier: enables
review:
summary: >-
Generic protein-binding annotation for the direct SOCS1-HIV-1 Gag interaction (via
SOCS1 SH2). Host-pathogen interaction, not core cellular physiology.
action: KEEP_AS_NON_CORE
reason: >-
Real direct interaction but virus-related and peripheral; generic term.
- term:
id: GO:0005515
label: protein binding
evidence_type: IPI
original_reference_id: PMID:31980649
qualifier: enables
review:
summary: >-
Generic protein-binding annotation from a large-scale KRAS/EGFR-network AP-MS study
(interaction with ELOC/Q15369). Uninformative term, high-throughput context.
action: MARK_AS_OVER_ANNOTATED
reason: >-
'protein binding' is uninformative; high-throughput interaction.
- term:
id: GO:0005515
label: protein binding
evidence_type: IPI
original_reference_id: PMID:32296183
qualifier: enables
review:
summary: >-
Generic protein-binding annotation from the HuRI binary interactome (interaction
with SH3GL1/Q99961). Uninformative term, context-free high-throughput screen.
action: MARK_AS_OVER_ANNOTATED
reason: >-
'protein binding' is uninformative; high-throughput interactome.
- term:
id: GO:0005515
label: protein binding
evidence_type: IPI
original_reference_id: PMID:35512704
qualifier: enables
review:
summary: >-
Generic protein-binding annotation from a cancer neoPPI screen (interaction with
SMAD4/Q13485). Uninformative term.
action: MARK_AS_OVER_ANNOTATED
reason: >-
'protein binding' is uninformative; high-throughput screen.
- term:
id: GO:0019210
label: kinase inhibitor activity
evidence_type: IEA
original_reference_id: GO_REF:0000107
qualifier: enables
review:
summary: >-
Kinase inhibitor activity transferred from the mouse ortholog. Correct in essence;
the more specific and experimentally supported term is protein kinase inhibitor
activity (GO:0004860).
action: MODIFY
reason: >-
Generalize-to-specific: SOCS1 specifically inhibits protein (tyrosine) kinases
(JAKs); replace with protein kinase inhibitor activity.
proposed_replacement_terms:
- id: GO:0004860
label: protein kinase inhibitor activity
- term:
id: GO:0043372
label: positive regulation of CD4-positive, alpha-beta T cell differentiation
evidence_type: IEA
original_reference_id: GO_REF:0000107
qualifier: involved_in
review:
summary: >-
T-cell differentiation role transferred electronically from the mouse ortholog
(O35716). Consistent with SOCS1's role in T-cell homeostasis but not a core
molecular function.
action: KEEP_AS_NON_CORE
reason: >-
Plausible from mouse ortholog; downstream immunophysiology, non-core.
- term:
id: GO:0043377
label: negative regulation of CD8-positive, alpha-beta T cell differentiation
evidence_type: IEA
original_reference_id: GO_REF:0000107
qualifier: involved_in
review:
summary: >-
Electronic transfer from the mouse ortholog. Consistent with SOCS1's T-cell
regulatory role; non-core.
action: KEEP_AS_NON_CORE
reason: >-
Plausible from mouse ortholog; downstream immunophysiology, non-core.
- term:
id: GO:0016567
label: protein ubiquitination
evidence_type: IEA
original_reference_id: GO_REF:0000041
qualifier: involved_in
review:
summary: >-
UniPathway-derived protein-ubiquitination annotation. Reflects SOCS1's SOCS-box E3
ubiquitin ligase substrate-recognition role, which targets bound substrates for
ubiquitination and proteasomal degradation.
action: ACCEPT
reason: >-
Core process consistent with the ECS(SOCS1) E3 ligase adaptor function
(PMID:17183367).
- term:
id: GO:0005654
label: nucleoplasm
evidence_type: IDA
original_reference_id: GO_REF:0000052
qualifier: located_in
review:
summary: >-
Immunofluorescence-based (HPA) nucleoplasm localization. SOCS1 has documented
nuclear pools and nuclear substrates; primary functional site remains cytoplasmic.
action: KEEP_AS_NON_CORE
reason: >-
Experimentally observed location; non-core relative to cytoplasmic JAK regulation.
- term:
id: GO:0030225
label: macrophage differentiation
evidence_type: IMP
original_reference_id: PMID:32634427
qualifier: involved_in
review:
summary: >-
SOCS1 (a miR-155-5p target) promotes macrophage M2 polarization via the PD1/PDL1
pathway in an immune thrombocytopenia model. Reflects a downstream contextual role
in macrophage biology.
action: KEEP_AS_NON_CORE
reason: >-
Experimental (IMP) but downstream/contextual; not a core molecular function.
Defer to curator on the precise differentiation term.
- term:
id: GO:0005515
label: protein binding
evidence_type: IPI
original_reference_id: PMID:23401859
qualifier: enables
review:
summary: >-
Generic protein-binding annotation from a DCNL1/CUL2-neddylation study (with
DCUN1D1/O14508). Consistent with SOCS1's CRL2/CRL5 substrate-receptor context but
recorded under the uninformative 'protein binding' term.
action: MARK_AS_OVER_ANNOTATED
reason: >-
'protein binding' is uninformative; interaction is contextual to CRL machinery.
- term:
id: GO:0043372
label: positive regulation of CD4-positive, alpha-beta T cell differentiation
evidence_type: ISS
original_reference_id: GO_REF:0000024
qualifier: involved_in
review:
summary: >-
Sequence-similarity transfer (from mouse O35716) of the CD4 T-cell differentiation
role; duplicates the IEA annotation above. Non-core.
action: KEEP_AS_NON_CORE
reason: >-
By-similarity immunophysiology; non-core.
- term:
id: GO:0043377
label: negative regulation of CD8-positive, alpha-beta T cell differentiation
evidence_type: ISS
original_reference_id: GO_REF:0000024
qualifier: involved_in
review:
summary: >-
Sequence-similarity transfer of the CD8 T-cell differentiation role; duplicates the
IEA annotation. Non-core.
action: KEEP_AS_NON_CORE
reason: >-
By-similarity immunophysiology; non-core.
- term:
id: GO:0045591
label: positive regulation of regulatory T cell differentiation
evidence_type: IMP
original_reference_id: PMID:22387553
qualifier: involved_in
review:
summary: >-
Annotation from a study of ILT3-induced CD8+ T suppressor cell differentiation in
which SOCS1 is a direct miR-155 target. The cached abstract does not clearly
establish a direct SOCS1 role in regulatory T cell differentiation; the supporting
detail is in full text not available here.
action: UNDECIDED
reason: >-
Cannot verify the specific Treg-differentiation claim from the cached abstract;
per guidelines use UNDECIDED rather than overruling the experimental annotation.
- term:
id: GO:0046426
label: negative regulation of receptor signaling pathway via JAK-STAT
evidence_type: IMP
original_reference_id: PMID:25019494
qualifier: involved_in
review:
summary: >-
Experimental support: miR-221 downregulation of SOCS1/SOCS3 potentiates IFN's
anti-HCV effect, with SOCS1/SOCS3 described as established inhibitors of the
IFN/JAK/STAT pathway. Reinforces the core negative-regulation function.
action: ACCEPT
reason: >-
Core JAK-STAT negative-regulation function, experimentally supported.
- term:
id: GO:0005829
label: cytosol
evidence_type: TAS
original_reference_id: Reactome:R-HSA-6785860
qualifier: located_in
review:
summary: >-
Cytosolic localization (Reactome). SOCS1 acts on receptor-associated JAKs in the
cytoplasm; this is its primary functional compartment.
action: ACCEPT
reason: >-
Primary site of action; consistent across sources.
- term:
id: GO:0005829
label: cytosol
evidence_type: TAS
original_reference_id: Reactome:R-HSA-877269
qualifier: located_in
review:
summary: >-
Cytosolic localization (Reactome), from the SOCS-1/SOCS-3 binding to p-JAK2 event.
Consistent with the core cytoplasmic JAK-regulation role.
action: ACCEPT
reason: >-
Primary functional compartment.
- term:
id: GO:0005829
label: cytosol
evidence_type: TAS
original_reference_id: Reactome:R-HSA-8983011
qualifier: located_in
review:
summary: >-
Cytosolic localization (Reactome). Redundant with other cytosol annotations.
action: ACCEPT
reason: >-
Consistent cytosolic localization.
- term:
id: GO:0005829
label: cytosol
evidence_type: TAS
original_reference_id: Reactome:R-HSA-9705738
qualifier: located_in
review:
summary: >-
Cytosolic localization (Reactome), from the SOCS1/3 CSF3R ubiquitination event.
Consistent with the SOCS-box E3 adaptor activity occurring in the cytoplasm.
action: ACCEPT
reason: >-
Consistent cytosolic localization.
- term:
id: GO:0005829
label: cytosol
evidence_type: TAS
original_reference_id: Reactome:R-NUL-1169195
qualifier: located_in
review:
summary: >-
Cytosolic localization (Reactome). Redundant cytosol annotation.
action: ACCEPT
reason: >-
Consistent cytosolic localization.
- term:
id: GO:0019210
label: kinase inhibitor activity
evidence_type: ISS
original_reference_id: GO_REF:0000024
qualifier: enables
review:
summary: >-
Sequence-similarity transfer of kinase inhibitor activity. As with the IEA version,
the specific supported term is protein kinase inhibitor activity (GO:0004860).
action: MODIFY
reason: >-
Generalize-to-specific: replace with protein kinase inhibitor activity.
proposed_replacement_terms:
- id: GO:0004860
label: protein kinase inhibitor activity
- term:
id: GO:0019221
label: cytokine-mediated signaling pathway
evidence_type: ISS
original_reference_id: GO_REF:0000024
qualifier: involved_in
review:
summary: >-
Sequence-similarity transfer placing SOCS1 in cytokine-mediated signaling. Correct
but general; SOCS1's specific role is negative regulation of JAK-STAT signaling.
action: KEEP_AS_NON_CORE
reason: >-
Correct but high-level; superseded by the specific negative-regulation term.
- term:
id: GO:0046426
label: negative regulation of receptor signaling pathway via JAK-STAT
evidence_type: ISS
original_reference_id: GO_REF:0000024
qualifier: involved_in
review:
summary: >-
Sequence-similarity transfer of the core JAK-STAT negative-regulation function.
Fully consistent with experimental evidence.
action: ACCEPT
reason: >-
Core SOCS1 function, corroborated experimentally and by orthology.
- term:
id: GO:0046627
label: negative regulation of insulin receptor signaling pathway
evidence_type: ISS
original_reference_id: GO_REF:0000024
qualifier: involved_in
review:
summary: >-
Sequence-similarity transfer (mouse O35716) of negative regulation of insulin
receptor signaling. SOCS1 is reported to attenuate insulin/IGF signaling (e.g. via
IRS targeting), but this is a secondary, context-specific role.
action: KEEP_AS_NON_CORE
reason: >-
Plausible secondary role; non-core relative to cytokine/JAK regulation.
- term:
id: GO:0005159
label: insulin-like growth factor receptor binding
evidence_type: IPI
original_reference_id: PMID:9727029
qualifier: enables
review:
summary: >-
IPI annotation supported by the explicit statement that hSOCS-1 interacts strongly
with IGF-IR in the two-hybrid assay. Real SH2-mediated interaction, but peripheral
to SOCS1's canonical cytokine-signaling role.
action: KEEP_AS_NON_CORE
reason: >-
Experimentally supported interaction (PMID:9727029) but a secondary,
receptor-specific binding rather than a core function.
- term:
id: GO:0019901
label: protein kinase binding
evidence_type: IPI
original_reference_id: PMID:9727029
qualifier: enables
review:
summary: >-
Protein kinase binding annotation (WITH JAK2/O60674). SOCS1 binding to activated
JAKs through its SH2 domain is central to its mechanism; protein kinase binding is
an informative, accurate molecular function.
action: ACCEPT
reason: >-
Captures SOCS1's mechanistically essential binding to JAK kinases; core function.
- term:
id: GO:0046426
label: negative regulation of receptor signaling pathway via JAK-STAT
evidence_type: NAS
original_reference_id: PMID:9727029
qualifier: involved_in
review:
summary: >-
Non-traceable author statement of the core JAK-STAT negative-regulation function.
Consistent with the wealth of experimental evidence even though the assertion here
is by analogy in a SOCS-2-focused paper.
action: ACCEPT
reason: >-
Core function; abundantly supported elsewhere (PMID:9202125, PMID:9202126).
- term:
id: GO:0004860
label: protein kinase inhibitor activity
evidence_type: TAS
original_reference_id: PMID:9202125
qualifier: enables
review:
summary: >-
Traceable-author-statement annotation of protein kinase inhibitor activity from the
founding SOCS family paper. This is the precise, experimentally grounded core
molecular function of SOCS1 (direct inhibition of JAK catalytic activity).
action: ACCEPT
reason: >-
Core molecular function; directly supported by PMID:9202125 and PMID:9202126.
- term:
id: GO:0005737
label: cytoplasm
evidence_type: TAS
original_reference_id: PMID:9202126
qualifier: located_in
review:
summary: >-
Cytoplasmic localization from the founding JAB paper. SOCS1 acts on cytoplasmic
receptor-associated JAKs; cytoplasm/cytosol is its principal compartment.
action: ACCEPT
reason: >-
Primary functional compartment; consistent with cytosol annotations.
proposed_new_terms: []
suggested_questions:
- question: >-
What is the full repertoire of physiological SOCS1 ubiquitination substrates beyond
JAKs (e.g. NF-kB RelA, IRS1/2, FAK), and which are degraded versus
non-degradatively regulated in primary immune cells?
- question: >-
How is the balance between SOCS1's direct kinase-inhibitory (KIR/SH2) activity and
its SOCS-box E3-adaptor activity tuned in different cytokine contexts?
suggested_experiments:
- description: >-
Separation-of-function mutants (KIR-dead vs SOCS-box-dead vs SH2-dead) expressed in
SOCS1-null cells, with quantitative phospho-JAK/STAT and substrate-degradation
readouts across IFN-gamma, IL2, IL4 and IL6 stimulation, to dissect the relative
contributions of kinase inhibition and ubiquitin-mediated degradation.
- description: >-
Proximity-labeling (BioID/TurboID) and ubiquitin-remnant proteomics in cytokine-
stimulated primary T cells/macrophages to define the endogenous SOCS1 interactome and
its degradation targets in a physiological setting.